(Q39597558)

13 September 2017

title

Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants (English)

1 reference

13 September 2017

4

Hanneke Schuitemaker

1 reference

13 September 2017

1

Diana Edo-Matas

1 reference

13 September 2017

5

Neeltje A Kootstra

1 reference

13 September 2017

Karel A van Dort

2

1 reference

13 September 2017

Laurentia C Setiawan

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

4 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

412

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

269-277

1 reference

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Single amino-acid changes in HIV envelope affect viral tropism and receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Association between CCR5 genotype and the clinical course of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Expression cloning of new receptors used by simian and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Maraviroc for previously treated patients with R5 HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

MODELTEST: testing the model of DNA substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Envelope V2 configuration and HIV-1 phenotype: clarification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Isolation and propagation of HIV-1 on peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.01.010

7 January 2021

10.1016/J.VIROL.2011.01.010

Identifiers

DOI

1 reference

13 September 2017

1 reference